The European Medicines Agency has recommended EU-wide approval of an updated version of Pfizer’s COVID-19 vaccine, Comirnaty, that is targeted to the Omicron XBB.1.5 sublineage of the SARS-CoV-2 virus.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?